Restrictive versus Liberal Transfusion Strategy in the Perioperative and Acute Care Settings: A Context-specific Systematic Review and Meta-analysis of Randomized Controlled Trials

Anesthesiology

Volumn 125, Issue 1, 2016, Pages 46-61

  Hovaguimian, Frédérique ^a,c   Myles, Paul S ^b  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; CLINICAL PROTOCOL; CRITICALLY ILL PATIENT; EMERGENCY CARE; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR SURGERY; META ANALYSIS; OXYGEN SUPPLY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SURGICAL MORTALITY; SURGICAL PATIENT; SYSTEMATIC REVIEW; ACUTE DISEASE; STANDARDS; TREATMENT OUTCOME;

ACUTE DISEASE; BLOOD TRANSFUSION; HUMANS; PERIOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84966714407     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000001162     Document Type: Article

References (86)

1. Shaw RE, Johnson CK, Ferrari G, Brizzio ME, Sayles K, Rioux N, Zapolanski A, Grau JB: Blood transfusion in cardiac surgery does increase the risk of 5-year mortality: Results from a contemporary series of 1714 propensity-matched patients. Transfusion 2014; 54:1106-13
2. Turan A, Yang D, Bonilla A, Shiba A, Sessler DI, Saager L, Kurz A: Morbidity and mortality after massive transfusion in patients undergoing non-cardiac surgery. Can J Anaesth 2013; 60:761-70
3. Glance LG, Dick AW, Mukamel DB, Fleming FJ, Zollo RA, Wissler R, Salloum R, Meredith UW, Osler TM: Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 2011; 114:283-92
4. Bernard AC, Davenport DL, Chang PK, Vaughan TB, Zwischenberger JB: Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg 2009; 208:931-7, 937. e1-2; discussion 938-9
5. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, MacIntyre NR, Shabot MM, Duh MS, Shapiro MJ: The CRIT Study: Anemia and blood transfusion in the critically ill-Current clinical practice in the United States. Crit Care Med 2004; 32:39-52
6. Carson JL, Brooks MM, Abbott JD, Chaitman B, Kelsey SF, Triulzi DJ, Srinivas V, Menegus MA, Marroquin OC, Rao SV, Noveck H, Passano E, Hardison RM, Smitherman T, Vagaonescu T, Wimmer NJ, Williams DO: Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J 2013; 165:964-971. e1
7. de Almeida JP, Vincent JL, Galas FR, de Almeida EP, Fukushima JT, Osawa EA, Bergamin F, Park CL, Nakamura RE, Fonseca SM, Cutait G, Alves JI, Bazan M, Vieira S, Sandrini AC, Palomba H, Ribeiro U Jr, Crippa A, Dalloglio M, Diz Mdel P, Kalil Filho R, Auler JO Jr, Rhodes A, Hajjar LA: Transfusion requirements in surgical oncology patients: A prospective, randomized controlled trial. Anesthesiology 2015; 122:29-38
8. Foss NB, Kristensen MT, Jensen PS, Palm H, Krasheninnikoff M, Kehlet H: The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery. Transfusion 2009; 49:227-34
9. Gregersen M, Borris LC, Damsgaard EM. Postoperative blood transfusion strategy in frail, anemic elderly patients with hip fracture. Acta Orthopaedica 2015:1-10
10. Rohde JM, Dimcheff DE, Blumberg N, Saint S, Langa KM, Kuhn L, Hickner A, Rogers MA: Health care-associated infection after red blood cell transfusion: A systematic review and meta-analysis. JAMA 2014; 311:1317-26
11. Brunskill SJ, Millette SL, Shokoohi A, Pulford EC, Doree C, Murphy MF, Stanworth S: Red blood cell transfusion for people undergoing hip fracture surgery. Cochrane Database Syst Rev 2015; 4:CD009699
12. Deeks J, Higgins J, Altman D. Chapter 9: Analysing data and undertaking meta-analyses, Cochrane Handbook for Systematic Reviews of Interventions Version 5. 1. 0 (updated March 2011). Edited by Higgins JPT, Green S. The Cochrane Collaboration, 2011. Available at: www. cochrane-handbook. org. Accessed March 30, 2016
13. Carson JL, Carless PA, Hebert PC: Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012; 4:CD002042
14. Curley GF, Shehata N, Mazer CD, Hare GM, Friedrich JO: Transfusion triggers for guiding RBC transfusion for cardiovascular surgery: A systematic review and meta-analysis. Crit Care Med 2014; 42:2611-24
15. Jairath V, Hearnshaw S, Brunskill SJ, Doree C, Hopewell S, Hyde C, Travis S, Murphy MF. Red cell transfusion for the management of upper gastrointestinal haemorrhage. Cochrane Database Syst Rev 2010:CD006613
16. Holst LB, Petersen MW, Haase N, Perner A, Wetterslev J: Restrictive versus liberal transfusion strategy for red blood cell transfusion: Systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ 2015; 350:h1354
17. Moher D, Liberati A, Tetzlaff J, Altman DG: PRISMA Group: Preferred reporting items for systematic reviews and metaanalyses: The PRISMA statement. BMJ 2009; 339:b2535
18. von Elm E, Poglia G, Walder B, Tramèr MR: Different patterns of duplicate publication: An analysis of articles used in systematic reviews. JAMA 2004; 291:974-80
19. Higgins J, Deeks J, Altman D. Chapter 16: Special topics in statistics, Cochrane Handbook for Systematic Reviews of Interventions, Version 5. 1. 0 (Updated March 2011). Edited by Higgins JPT, Green S. The Cochrane Collaboration, 2011. Available at: www. cochrane-handbook. org. Accessed March 30, 2016
20. Vanderlinde ES, Heal JM, Blumberg N: Autologous transfusion. BMJ 2002; 324:772-5
21. Carless P, Moxey A, O'Connell D, Henry D: Autologous transfusion techniques: A systematic review of their efficacy. Transfus Med 2004; 14:123-44
22. Kim TH, Koh YS, Chang K, Seo SM, Kim CJ, Park HJ, Kim PJ, Her SH, Kim DB, Lee JM, Park CS, Kim HY, Yoo KD, Jeon DS, Park JH, Chung WS, Seung KB: CathOlic university of Korea-percutAneous Coronary inTervention Registry Investigators: Improved anemia is associated with favorable long-term clinical outcomes in patients undergoing PCI. Coron Artery Dis 2012; 23:391-9
23. Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G, Sharma SC, Vezeridis M, Khuri SF, Friedmann PD: Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007; 297:2481-8
24. Sakr Y, Lobo S, Knuepfer S, Esser E, Bauer M, Settmacher U, Barz D, Reinhart K: Anemia and blood transfusion in a surgical intensive care unit. Crit Care 2010; 14:R92
25. Saager L, Turan A, Reynolds LF, Dalton JE, Mascha EJ, Kurz A: The association between preoperative anemia and 30-day mortality and morbidity in noncardiac surgical patients. Anesth Analg 2013; 117:909-15
26. Sekhon MS, McLean N, Henderson WR, Chittock DR, Griesdale DE: Association of hemoglobin concentration and mortality in critically ill patients with severe traumatic brain injury. Crit Care 2012; 16:R128
27. Shema-Didi L, Ore L, Geron R, Kristal B: Is anemia at hospital admission associated with in-hospital acute kidney injury occurrence? Nephron Clin Pract 2010; 115:c168-76
28. De Santo L, Romano G, Della Corte A, de Simone V, Grimaldi F, Cotrufo M, de Feo M: Preoperative anemia in patients undergoing coronary artery bypass grafting predicts acute kidney injury. J Thorac Cardiovasc Surg 2009; 138:965-70
29. Montori VM, Permanyer-Miralda G, Ferreira-González I, Busse JW, Pacheco-Huergo V, Bryant D, Alonso J, Akl EA, Domingo-Salvany A, Mills E, Wu P, Schünemann HJ, Jaeschke R, Guyatt GH: Validity of composite end points in clinical trials. BMJ 2005; 330:594-6
30. Myles PS, Devereaux PJ: Pros and cons of composite endpoints in anesthesia trials. Anesthesiology 2010; 113:776-8
31. Wallis JP, Wells AW, Whitehead S, Brewster N: Recovery from post-operative anaemia. Transfus Med 2005; 15:413-8
32. Bateman AP, McArdle F, Walsh TS: Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis. Crit Care Med 2009; 37:1906-12
33. Cata JP, Wang H, Gottumukkala V, Reuben J, Sessler DI: Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth 2013; 110:690-701
34. Refaai MA, Blumberg N: Transfusion immunomodulation from a clinical perspective: An update. Expert Rev Hematol 2013; 6:653-63
35. Jairath V, Kahan BC, Gray A, Doré CJ, Mora A, James MW, Stanley AJ, Everett SM, Bailey AA, Dallal H, Greenaway J, Le Jeune I, Darwent M, Church N, Reckless I, Hodge R, Dyer C, Meredith S, Llewelyn C, Palmer KR, Logan RF, Travis SP, Walsh TS, Murphy MF: Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): A pragmatic, open-label, cluster randomised feasibility trial. Lancet 2015; 386:137-44
36. Walsh TS, Boyd JA, Watson D, Hope D, Lewis S, Krishan A, Forbes JF, Ramsay P, Pearse R, Wallis C, Cairns C, Cole S, Wyncoll D: RELIEVE Investigators: Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: A randomized pilot trial. Crit Care Med 2013; 41:2354-63
37. Higgins J, Altman D, Sterne J. Chapter 8: Assessing risk of bias in included studies, Cochrane Handbook for Systematic Reviews of Interventions Version 5. 1. 0 (Updated March 2011). Edited by Higgins JPT, Green S. The Cochrane Collaboration, 2011. Available at: www. cochrane-handbook. org. Accessed March 30, 2016
38. Loke Y, Price D, A H. Chapter 14: Adverse effects, Cochrane Handbook for Systematic Reviews of Interventions Version 5. 1. 0 (Updated March 2011). Edited by Higgins JPT, Green S. The Cochrane Collaboration, 2011. Available at: www. cochrane-handbook. org. Accessed March 30, 2016
39. Sedgwick P. Meta-analyses: Heterogeneity and subgroup analysis. BMJ 2013; 346:f4040
40. Groenwold RH, Rovers MM, Lubsen J, van der Heijden GJ: Subgroup effects despite homogeneous heterogeneity test results. BMC Med Res Methodol 2010; 10:43
41. Gregersen M, Damsgaard EM, Borris LC: Blood transfusion and risk of infection in frail elderly after hip fracture surgery: The TRIFE randomized controlled trial. Eur J Orthop Surg Traumatol 2015; 25:1031-8
42. Gregersen M, Borris LC, Damsgaard EM: Blood transfusion and overall quality of life after hip fracture in frail elderly patients-The transfusion requirements in frail elderly randomized controlled trial. J Am Med Dir Assoc 2015; 16:762-6
43. Slight RD, Fung AK, Alonzi C, Bappu NJ, McClelland DB, Mankad PS: Rationalizing blood transfusion in cardiac surgery: Preliminary findings with a red cell volume-based model. Vox Sang 2007; 92:154-6
44. Gruber-Baldini AL, Marcantonio E, Orwig D, Magaziner J, Terrin M, Barr E, Brown JP, Paris B, Zagorin A, Roffey DM, Zakriya K, Blute MR, Hebel JR, Carson JL: Delirium outcomes in a randomized trial of blood transfusion thresholds in hospitalized older adults with hip fracture. J Am Geriatr Soc 2013; 61:1286-95
45. Carson JL, Sieber F, Cook DR, Hoover DR, Noveck H, Chaitman BR, Fleisher L, Beaupre L, Macaulay W, Rhoads GG, Paris B, Zagorin A, Sanders DW, Zakriya KJ, Magaziner J: Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial. Lancet 2015; 385:1183-9
46. Jiwaji Z, Nunn KP, Conway-Morris A, Simpson AJ, Wyncoll D, Rossi AG, Walsh TS: RELIEVE Trial Investigators: Leukoreduced blood transfusion does not increase circulating soluble markers of inflammation: A randomized controlled trial. Transfusion 2014; 54:2404-11
47. Bracey AW, Radovancevic R, Riggs SA, Houston S, Cozart H, Vaughn WK, Radovancevic B, McAllister HA Jr, Cooley DA: Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: Effect on patient outcome. Transfusion 1999; 39:1070-7
48. Bush RL, Pevec WC, Holcroft JW: A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients. Am J Surg 1997; 174:143-8
49. Carson JL, Terrin ML, Barton FB, Aaron R, Greenburg AG, Heck DA, Magaziner J, Merlino FE, Bunce G, McClelland B, Duff A, Noveck H: A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion 1998; 38:522-9
50. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K, Macaulay W, Lewis C, Cook DR, Dobbin G, Zakriya KJ, Apple FS, Horney RA, Magaziner J: FOCUS Investigators: Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365:2453-62
51. Cooper HA, Rao SV, Greenberg MD, Rumsey MP, McKenzie M, Alcorn KW, Panza JA: Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). Am J Cardiol 2011; 108:1108-11
52. Fan YX, Liu FF, Jia M, Yang JJ, Shen JC, Zhu GM, Zhu SH, Li WY, Yang JJ, Ji MH: Comparison of restrictive and liberal transfusion strategy on postoperative delirium in aged patients following total hip replacement: A preliminary study. Arch Gerontol Geriatr 2014; 59:181-5
53. Fortune JB, Feustel PJ, Saifi J, Stratton HH, Newell JC, Shah DM: Influence of hematocrit on cardiopulmonary function after acute hemorrhage. J Trauma 1987; 27:243-9
54. Grover M, Talwalkar S, Casbard A, Boralessa H, Contreras M, Boralessa H, Brett S, Goldhill DR, Soni N: Silent myocardial ischaemia and haemoglobin concentration: A randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sang 2006; 90:105-12
55. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, Fukushima J, Kalil Filho R, Sierra DB, Lopes NH, Mauad T, Roquim AC, Sundin MR, Leão WC, Almeida JP, Pomerantzeff PM, Dallan LO, Jatene FB, Stolf NA, Auler JO Jr: Transfusion requirements after cardiac surgery: The TRACS randomized controlled trial. JAMA 2010; 304:1559-67
56. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340:409-17
57. Hébert PC, Wells G, Marshall J, Martin C, Tweeddale M, Pagliarello G, Blajchman M: Transfusion requirements in critical care. A pilot study. Canadian Critical Care Trials Group. JAMA 1995; 273:1439-44
58. Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, Johansson PI, Aneman A, Vang ML, Winding R, Nebrich L, Nibro HL, Rasmussen BS, Lauridsen JR, Nielsen JS, Oldner A, Pettilä V, Cronhjort MB, Andersen LH, Pedersen UG, Reiter N, Wiis J, White JO, Russell L, Thornberg KJ, Hjortrup PB, Müller RG, Møller MH, Steensen M, Tjäder I, Kilsand K, Odeberg-Wernerman S, Sjøbø B, Bundgaard H, Thyø MA, Lodahl D, Markedahl R, Albeck C, Illum D, Kruse M, Winkel P, Perner A: TRISS Trial Group: Scandinavian Critical Care Trials Group: Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014; 371:1381-91
59. Markatou M, Theodoraki K, Rizos D, Fassoulaki A: Targeting perioperative haemoglobin in major abdominal surgery. J Anesth Clin Res 2012; 3:1-6
60. Murphy GJ, Pike K, Rogers CA, Wordsworth S, Stokes EA, Angelini GD, Reeves BC: TITRe2 Investigators: Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 2015; 372:997-1008
61. Naidech AM, Shaibani A, Garg RK, Duran IM, Liebling SM, Bassin SL, Bendok BR, Bernstein RA, Batjer HH, Alberts MJ: Prospective, randomized trial of higher goal hemoglobin after subarachnoid hemorrhage. Neurocrit Care 2010; 13:313-20
62. Nielsen K, Johansson PI, Dahl B, Wagner M, Frausing B, Børglum J, Jensen K, Stürup J, Hvolris J, Rasmussen LS: Perioperative transfusion threshold and ambulation after hip revision surgery-A randomized trial. BMC Anesthesiol 2014; 14:89
63. Parker MJ: Randomised trial of blood transfusion versus a restrictive transfusion policy after hip fracture surgery. Injury 2013; 44:1916-8
64. Prick BW, Jansen AJ, Steegers EA, Hop WC, Essink-Bot ML, Uyl-de Groot CA, Akerboom BM, van Alphen M, Bloemenkamp KW, Boers KE, Bremer HA, Kwee A, van Loon AJ, Metz GC, Papatsonis DN, van der Post JA, Porath MM, Rijnders RJ, Roumen FJ, Scheepers HC, Schippers DH, Schuitemaker NW, Stigter RH, Woiski MD, Mol BW, van Rhenen DJ, Duvekot JJ: Transfusion policy after severe postpartum haemorrhage: A randomised non-inferiority trial. BJOG 2014; 121:1005-14
65. Robertson CS, Hannay HJ, Yamal JM, Gopinath S, Goodman JC, Tilley BC, Baldwin A, Rivera Lara L, Saucedo-Crespo H, Ahmed O, Sadasivan S, Ponce L, Cruz-Navarro J, Shahin H, Aisiku IP, Doshi P, Valadka A, Neipert L, Waguspack JM, Rubin ML, Benoit JS, Swank P: Epo Severe TBI Trial Investigators: Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: A randomized clinical trial. JAMA 2014; 312:36-47
66. Shehata N, Burns LA, Nathan H, Hebert P, Hare GM, Fergusson D, Mazer CD: A randomized controlled pilot study of adherence to transfusion strategies in cardiac surgery. Transfusion 2012; 52:91-9
67. Slight RD, O'Donohoe P, Fung AK, Alonzi C, McClelland DB, Mankad PS: Rationalizing blood transfusion in cardiac surgery: The impact of a red cell volume-based guideline on blood usage and clinical outcome. Vox Sang 2008; 95:205-10
68. So-Osman C, Nelissen R, Te Slaa R, Coene L, Brand R, Brand A: A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte-depleted red blood cells. Vox Sang 2010; 98:56-64
69. Topley E, Fisher MR. The illness of trauma. Br J Clin Pract 1956; 10: 770-6
70. Villanueva C, Colomo A, Bosch A, Concepción M, Hernandez-Gea V, Aracil C, Graupera I, Poca M, Alvarez-Urturi C, Gordillo J, Guarner-Argente C, Santaló M, Muñiz E, Guarner C: Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368:11-21
71. Webert KE, Cook RJ, Couban S, Carruthers J, Lee KA, Blajchman MA, Lipton JH, Brandwein JM, Heddle NM: A multicenter pilotrandomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion 2008; 48:81-91
72. Freudenberger RS, Carson JL: Is there an optimal hemoglobin value in the cardiac intensive care unit? Curr Opin Crit Care 2003; 9:356-61
73. Spinelli E, Bartlett RH: Anemia and transfusion in critical care: Physiology and management. J Intensive Care Med 2015:1-12
74. Roberts I, Shakur H, Ker K, Coats T: CRASH-2 Trial Collaborators: Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev 2012; 12:CD004896
75. Sørensen B, Spahn DR, Innerhofer P, Spannagl M, Rossaint R: Clinical review: Prothrombin complex concentrates-Evaluation of safety and thrombogenicity. Crit Care 2011; 15:201
76. Ortmann E, Besser MW, Klein AA: Antifibrinolytic agents in current anaesthetic practice. Br J Anaesth 2013; 111:549-63
77. Tanaka KA, Esper S, Bolliger D: Perioperative factor concentrate therapy. Br J Anaesth 2013; 111(suppl 1):i35-49
78. Juffermans NP, Prins DJ, Vlaar AP, Nieuwland R, Binnekade JM: Transfusion-related risk of secondary bacterial infections in sepsis patients: A retrospective cohort study. Shock 2011; 35:355-9
79. Subramanian A, Berbari EF, Brown MJ, Allen MS, Alsara A, Kor DJ: Plasma transfusion is associated with postoperative infectious complications following esophageal resection surgery: A retrospective cohort study. J Cardiothorac Vasc Anesth 2012; 26:569-74
80. Görlinger K, Saner FH: Prophylactic plasma and platelet transfusion in the critically Ill patient: Just useless and expensive or even harmful? BMC Anesthesiol 2015; 15:86
81. Williams ML, He X, Rankin JS, Slaughter MS, Gammie JS: Preoperative hematocrit is a powerful predictor of adverse outcomes in coronary artery bypass graft surgery: A report from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 2013; 96:1628-34; discussion 1634
82. Weber WP, Zwahlen M, Reck S, Misteli H, Rosenthal R, Buser AS, Kaufmann M, Oertli D, Widmer AF, Marti WR: The association of preoperative anemia and perioperative allogeneic blood transfusion with the risk of surgical site infection. Transfusion 2009; 49:1964-70
83. Hogan BV, Peter MB, Shenoy HG, Horgan K, Hughes TA: Surgery induced immunosuppression. Surgeon 2011; 9:38-43
84. Roubinian NH, Carson JL: Restrictive red blood cell transfusion strategies appear safe in most clinical settings. Evid Based Med 2015; 20:170
85. Klein HG, Flegel WA, Natanson C: Red blood cell transfusion: Precision vs imprecision medicine. JAMA 2015:1-2
86. Docherty AB, O'Donnell R, Brunskill S, Trivella M, Doree C, Holst L, Parker M, Gregersen M, Pinheiro de Almeida J, Walsh TS, Stanworth SJ: Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: Systematic review and meta-analysis. BMJ 2016; 352:i1351